<i>Science Signaling</i> Podcast: 12 February 2013

Gregg L. Friedman; Maimon E. Hubbi; Annalisa M. VanHook

doi:10.1126/scisignal.2004007

Article2001

FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity

Patrick C. Mahon, Kiichi Hirota, Gregg L. Friedman

Article2008

n-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems

Motohide Kimura, Satoshi Takabuchi, Tomoharu Tanaka, Miyahiko Murata, Kenichiro Nishi, Seiko Oda, Tomoyuki Oda, Michiyuki Kanai, Kazuhiko Fukuda, Shinae Kizaka‐Kondoh, Takehiko Adachi, Arimichi Takabayashi, Gregg L. Friedman, Kiichi Hirota

Article2019

IL4Rα Signaling Abrogates Hypoxic Neutrophil Survival and Limits Acute Lung Injury Responses <i>In Vivo</i>

A.J. Harris, Ananda S. Mirchandani, Ruairi Lynch, Fiona Murphy, Liam Delaney, Donna M. Small, Patrícia Coelho, Emily Watts, Pranvera Sadiku, David Griffith, Rebecca Dickinson, Eilidh Clark, Joseph Willson, Tyler Morrison, Massimiliano Mazzone, Peter Carmeliet, Bart Ghesquière, Cecilia M. O’Kane, Daniel F. McAuley, Steve Jenkins, Moira K. B. Whyte, Sarah R. Walmsley

Article2012

Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2

Nanduri R. Prabhakar, Gregg L. Friedman

Article2012

Cancer Metabolism, HIF‐1, and Novel Anti‐Cancer Therapies

Gregg L. Friedman

<i>Science Signaling</i> Podcast: 12 February 2013

Abstract

Discussion(0)

Related publications

FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity

n-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems

IL4Rα Signaling Abrogates Hypoxic Neutrophil Survival and Limits Acute Lung Injury Responses <i>In Vivo</i>

Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2

Cancer Metabolism, HIF‐1, and Novel Anti‐Cancer Therapies